Prime Organics, Inc. And Massachusetts General Hospital Sign Option Agreement On Alzheimer's Disease Technology
10/19/2005 5:09:45 PM
Prime Organics, Inc., announced today that it has reached agreement with Massachusetts General Hospital to develop new technology in the fight against Alzheimer's disease (AD). Prime has signed an option agreement for the exclusive rights to a class of compounds invented by Dr. Xudong Huang, an Assistant Professor in the Departments of Psychiatry at MGH and Harvard Medical School.
comments powered by